News | April 22, 2015

3-T MRI Advancing on Ultrasound for Imaging Fetal Abnormalities

Higher field strength improves image quality but raises concerns about radiation dose to the fetus

April 22, 2015 — Although ultrasound remains the primary imaging modality used in prenatal imaging, fetal magnetic resonance imaging (MRI) is playing an increasing role in further evaluation of fetuses suspected of congenital anomalies. As 3-T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3-T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.

"MRI is playing an increasingly important role in the assessment of complex prenatal disease," said Kathleen E. Carey, M.D., Mayo Clinic, Jacksonville, Florida. "The use of stronger 3-T field strengths may allow for improved visualization of subcutaneous fat and osseous structures, including the hands and feet of the developing fetus."

The study is featured in an electronic exhibit at the American Roentgen Ray Society (ARRS) 2015 annual meeting in Toronto.

First attempted in the 1980s, MRI in pregnancy has maintained a steady growth rate. Recent studies have demonstrated that fetal MRI not only provides good detail of normal fetal anatomy and allows characterization of suspected anomalies but also may alter the diagnosis provided by ultrasound, uncovering fetal anomalies earlier and more accurately. Currently, clinical MRI is most frequently performed on 1.5-T MRI systems, but 3-T scanners are becoming more common around the world as the search for improved image signal-to-noise ratio and anatomic detail grows. This developmental opportunity must be weighed against potential risks to the fetus, taking into account the specific absorption rate.

ARRS will present a series of fetal MRI cases and discuss the anatomic and imaging findings, indication for MRI, diagnosis and impact on patient management. The benefits and limitations of fetal MRI at 1.5-T and 3-T field strengths will be discussed, and future advanced imaging will be considered, including spectroscopy and diffusion tensor imaging.

For more information: www.arrs.org

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.